Eversept Partners’s STAAR Surgical STAA Stock Holding History

Eversept Partners’s Portfolio STAA Stock Details STAA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-91,199	Closed	-$3.39M	–	77
2024 Q3	$3.39M	Buy	+91,199	New	+$3.4M	0.23%	48

Other funds holding STAA

Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

RAM

Resona Asset Management Koto-Ku,tokyo, Japan $20.1B AUM 26.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

ACM

American Capital Management New York $1.86B AUM 20.23% 1-Year Est. Return

Eversept Partners's STAA Position: Q4 2024 in Review

Eversept Partners sold out of STAAR Surgical (STAA) in Q4 2024, closing a stake of 91,199 shares — an estimated $3.39M sold.

Eversept Partners first reported a position in STAA in Q3 2024 and held it in 1 quarter. The position peaked at $3.39M in Q3 2024. 212 funds tracked by Wall St. Rank hold STAA as of Q4 2024.

Eversept Partners reported no remaining STAAR Surgical position as of Q4 2024 after selling out during the quarter.
Eversept Partners sold 91,199 STAAR Surgical shares in Q4 2024, an estimated $3.39M.
Eversept Partners first reported a position in STAAR Surgical in Q3 2024 and held it in 1 quarter.
Eversept Partners's STAAR Surgical position peaked at $3.39M in Q3 2024.
212 funds tracked by Wall St. Rank held STAAR Surgical as of Q4 2024.

Based on Eversept Partners's 13F filing for Q4 2024, filed 14 Feb 2025.